Surface Oncology, Inc.·4

May 5, 6:50 PM ET

RATH HENRY C. 4

4 · Surface Oncology, Inc. · Filed May 5, 2021

Insider Transaction Report

Form 4
Period: 2021-05-03
RATH HENRY C.
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-05-03+140,000140,000 total
    Exercise: $7.33Exp: 2031-05-03Common Stock (140,000 underlying)
Footnotes (1)
  • [F1]This option shall vest as follows: 25% of the shares shall vest on April 26, 2022, and the remaining shares shall vest in 36 equal monthly installments, so long as the reporting person remains an employee or other service provider of the Company on such dates.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION